Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$64.63
+0.7%
$58.71
$42.52
$68.10
$132.20B0.2213.26 million shs7.21 million shs
GSK PLC Sponsored ADR stock logo
GSK
GSK
$53.08
+1.7%
$51.80
$37.67
$61.69
$107.12B0.364.66 million shs2.52 million shs
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$348.27
+5.6%
$296.52
$253.95
$385.22
$38.21B0.49391,952 shs638,115 shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.70
+1.9%
$25.02
$23.58
$28.75
$152.52B0.3440.98 million shs42.71 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.00%-1.23%+11.64%+15.21%+44.18%
GSK PLC Sponsored ADR stock logo
GSK
GSK
0.00%+2.62%+1.08%+5.36%+44.30%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
0.00%+10.21%+15.01%+11.58%+16.67%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+6.39%+10.27%+4.12%+11.50%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$64.63
+0.7%
$58.71
$42.52
$68.10
$132.20B0.2213.26 million shs7.21 million shs
GSK PLC Sponsored ADR stock logo
GSK
GSK
$53.08
+1.7%
$51.80
$37.67
$61.69
$107.12B0.364.66 million shs2.52 million shs
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$348.27
+5.6%
$296.52
$253.95
$385.22
$38.21B0.49391,952 shs638,115 shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.70
+1.9%
$25.02
$23.58
$28.75
$152.52B0.3440.98 million shs42.71 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.00%-1.23%+11.64%+15.21%+44.18%
GSK PLC Sponsored ADR stock logo
GSK
GSK
0.00%+2.62%+1.08%+5.36%+44.30%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
0.00%+10.21%+15.01%+11.58%+16.67%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+6.39%+10.27%+4.12%+11.50%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.52
Moderate Buy$66.062.21% Upside
GSK PLC Sponsored ADR stock logo
GSK
GSK
2.10
Hold$53.00-0.15% Downside
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
2.88
Moderate Buy$400.0014.85% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.19
Hold$28.285.90% Upside

Current Analyst Ratings Breakdown

Latest ONC, PFE, BMY, and GSK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetBuy$35.00 ➝ $31.00
8/6/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Reiterated RatingOverweight
8/6/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Reiterated RatingOutperform
8/6/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Boost Price TargetOverweight$403.00 ➝ $407.00
8/6/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Boost Price TargetBuy$424.00 ➝ $454.00
8/6/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Lower Price TargetOutperform$451.00 ➝ $450.00
8/6/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Boost Price TargetBuy$416.00 ➝ $418.00
8/6/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Boost Price TargetBuy$420.00 ➝ $430.00
8/6/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Boost Price TargetMarket Outperform$396.00 ➝ $405.00
8/5/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Initiated CoverageMarket PerformStrong-Buy
8/5/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Initiated CoverageHoldBuy
(Data available from 8/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$48.19B2.74$8.12 per share7.96$10.93 per share5.91
GSK PLC Sponsored ADR stock logo
GSK
GSK
$43.07B2.49$6.02 per share8.82$11.40 per share4.66
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$5.34B7.15$3.91 per share89.11$47.16 per share7.38
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.43$4.38 per share6.09$15.00 per share1.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$7.05B$4.5414.2410.110.1718.87%66.90%14.74%N/A
GSK PLC Sponsored ADR stock logo
GSK
GSK
$7.54B$3.2016.6010.333.0414.56%43.23%11.60%10/28/2026 (Estimated)
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$286.93M$4.4761.3231.32N/A10.70%14.23%7.82%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$0.7635.149.11N/A6.80%19.63%8.46%N/A

Latest ONC, PFE, BMY, and GSK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$1.40$2.05+$0.65$2.05$1.66 billion$1.71 billion
8/4/2026Q2 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.6820$0.77+$0.0880-$0.04$14.40 billion$15.03 billion
7/30/2026Q2 2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$1.60$2.04+$0.44$1.62$11.74 billion$12.97 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$2.523.90%+1.61%55.51%17 Years
GSK PLC Sponsored ADR stock logo
GSK
GSK
$1.773.33%-7.86%55.31%N/A
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.44%-13.20%226.32%16 Years

Latest ONC, PFE, BMY, and GSK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
GSK PLC Sponsored ADR stock logo
GSK
GSK
quarterly$0.45153.36%8/14/20268/14/202610/8/2026
6/24/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.01%7/24/20267/24/20269/1/2026
6/17/2026
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
quarterly$0.634.34%7/2/20267/2/20268/3/2026
1/1/2100
GSK PLC Sponsored ADR stock logo
GSK
GSK
quarterly$0.42064.3%8/15/20258/15/202510/9/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
1.89
1.53
1.38
GSK PLC Sponsored ADR stock logo
GSK
GSK
0.81
0.82
0.52
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
0.17
3.40
3.27
Pfizer Inc. stock logo
PFE
Pfizer
0.71
1.27
0.94

Institutional Ownership

CompanyInstitutional Ownership
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
76.41%
GSK PLC Sponsored ADR stock logo
GSK
GSK
15.74%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
48.55%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.05%
GSK PLC Sponsored ADR stock logo
GSK
GSK
10.00%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
6.19%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
32,5002.04 billion2.04 billionOptionable
GSK PLC Sponsored ADR stock logo
GSK
GSK
66,8412.02 billion1.82 billionOptionable
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
12,000109.72 million102.93 millionN/A
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Pfizer Advances COVID Pipeline As Analysts Eye Upside
Pfizer (NYSE:PFE) Stock Price Up 1.9% - Here's What Happened
Monster insider trading alert for Pfizer stock
Czech National Bank Buys 73,802 Shares of Pfizer Inc. $PFE
Pfizer Inc. $PFE Shares Sold by Sarasin & Partners LLP
Pfizer (NYSE:PFE) Shares Up 1.4% After Better-Than-Expected Earnings
Pfizer (NYSE:PFE) Trading 1.4% Higher - Here's Why

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bristol Myers Squibb stock logo

Bristol Myers Squibb NYSE:BMY

$64.63 +0.48 (+0.75%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$64.02 -0.61 (-0.94%)
As of 08/7/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

GSK stock logo

GSK NYSE:GSK

$53.08 +0.91 (+1.74%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$53.12 +0.04 (+0.07%)
As of 08/7/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

BeOne Medicines stock logo

BeOne Medicines NASDAQ:ONC

$348.27 +18.47 (+5.60%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$344.62 -3.64 (-1.05%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Pfizer stock logo

Pfizer NYSE:PFE

$26.70 +0.50 (+1.92%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$26.65 -0.05 (-0.20%)
As of 08/7/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.